HomeRVPHW • NASDAQ
add
Reviva Pharmaceuticals
Previous close
$0.30
Day range
$0.25 - $0.27
Year range
$0.25 - $2.70
Market cap
43.27M USD
Avg Volume
16.16K
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.92M | 17.62% |
Net income | -7.43M | -12.59% |
Net profit margin | — | — |
Earnings per share | -0.25 | 16.67% |
EBITDA | — | — |
Effective tax rate | -0.10% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.97M | 6.38% |
Total assets | 13.50M | 4.61% |
Total liabilities | 14.84M | 108.56% |
Total equity | -1.35M | — |
Shares outstanding | 27.92M | — |
Price to book | -6.00 | — |
Return on assets | -106.49% | — |
Return on capital | -841.90% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -7.43M | -12.59% |
Cash from operations | -11.73M | -47.47% |
Cash from investing | — | — |
Cash from financing | 332.00K | -51.68% |
Net change in cash | -11.39M | -56.85% |
Free cash flow | -9.16M | -64.95% |
About
Founded
2018
Headquarters
Website
Employees
15